Zydus Lifesciences launches Rexigo
This is the first and only oral once-a-day therapy for testosterone suppression in patients with advanced prostate cancer in India
This is the first and only oral once-a-day therapy for testosterone suppression in patients with advanced prostate cancer in India
Exblifeb demonstrates remarkable efficacy in treating complicated Urinary Tract Infections (cUTI), pneumonia
About 75% of all primary liver cancers in adults are HCC and up to 30% of HCC patients are eligible for embolisation
Union Ayush Minister with Assam Chief Minister lays foundation stone for Central Research Institute of Yoga & Naturopathy
Combines biocompatibility, heat-resistance, transparency and durability
Pivotal trial found the enfortumab vedotin plus pembrolizumab combination significantly extended overall and progression-free survival
The initiative is a response to the rising incidents of heart attacks and cardiac arrests in the state
The company will be preferred business partner for VPPL in terms of sourcing and supplying key raw materials
The new campus has been designed as an employee-centred experience and ecosystem zone
Subscribe To Our Newsletter & Stay Updated